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Acute effects of a meat meal on renal hemodynamics and renal
excretory function. J.F.M. Wetz.e/s, E.M.v. Dovnhoven, A.J. Hoitsma,
RAP. Koene. Depart,ne,it ot Medicine, Division of Nephrologv,
University Hospital, Nijinegen, The Netherlands. To determine the
effects of a protein load on tubular sodium handling we have studied the
effects of a meat meal on renal hemodynamics and renal excretory
function in 10 healthy volunteers (9 M, I F) with a mean (± so) age of
23 2 years'cnd a mean body weight of 71 12 kg. Volunteers were
studied during maximal water diuresis. Glomerular filtration rate (GFR)
and effective renal plasma flow (ERPF) were measured using clearances
of inulin and PAL-I, respectively. Free water clearance and lithium
clearance were used to calculate proximal and distal sodium reabsorp-
(ion. After obtaining baseline values a meat meal (1.8 g protein/kg body
wt) or placebo containing equivalent amounts of sodium and phosphate
was administered, and measurements were continued for four hours.
After the meat meal urine flow increased from 15.3 1.0 mI/mm to a
maximal mean value of 20.1 3.2 mI/mm (mean SEM; P < 0.01),
whereas urine flow did not change after placebo. Maximal mean (±
sEM) changes compared to baseline values for GFR, ERPF, fractional
excretion of sodium (FENA) and tubular secretory clearance of creat-
mine (TScreat) are given in the Table.
Meat
Placebo
GFR
mi/mm
10.4 2.9
—4.5 2.0
ERPF
mi/mm
42 16.7"
—5.2 15.3
FEN
%
1.07
0.25
a"
O.l7
0.06
TScreat
,ni/min
17.0 2.3"
4.2 2.4
The increase of FENA was the result of both a decrease of proximal
and distal sodium reabsorption (respectively, —2.8 0.6%, P < 0.05;
and —7.5 2.3%, P < 0.05). In conclusion: an acute meat meal
increases urinary sodium excretion more than would be expected from
the changes in renal hemodynaniics. This suggests direct interference
with proximal and distal tubular sodium reabsorption. Creatinine secre-
tion is increased, invalidating creatinine as a marker of GFR in this kind
of study.
Effects of acute and chronic protein stimulation on renal function in
patients with chronic renal insufficiency. H.J.G. Bib, G.H. Schaap,
ROB. (laos, P.L. Oe. A.J.M. Donker. Free University Hospital,
Amsterdam, The Netherlands. In chronic renal failure (CRF) early
protein restriction is considered beneficial, probably by lowering hy-
perfiltration in still functioning nephrons. In an earlier study in CRF
patients, we found a difference in GFR and ERPF when comparing
measurements after a 4 week period of low protein intake (LP) with a 4
week period of high protein intake (HP). We suggested a reintroduction
of functional renal reserve capacity (FRRC) after the LP diet. In the
present study we examined the effects of 4 weeks LP and 4 weeks HP
under basal conditions and after stimulation with a combination of oral
Clinifeed-protemn rich and an amino acid infusion in 9 patients with
CRF.
LP HP
basal(B) stim(S) basal(B) stim(S)
GFR 41 9 49 10" 45 53 II"
ERPF 167 39 197 35b 180 4Ø 220 49C
Mean sr; paired two-tailed Wilcoxon; a P < 0.02 LP vs. HP; b p
< 0.02; C P < 0.01 B vs. S
Again a difference could be found between LP and HP, especially under
basal conditions (GFR: median difference + 12.3%, ERPF: + 12.2%). It
was possible, however, to stimulate renal function after both dietary
periods with comparable results (LP:GFR:median difference + 20%,
ERPF:+ 23.3%, HP:GFR:+ 16%, ERPF:+ 22.4%). These results
suggest different mechanisms for acute and chronic stimulation of renal
function, also in patients with chronic renal insufficiency. It contradicts
earlier reports that FRRC is absent when GFR values are below 50
ml/min/l.73 m2, and secondly, that FRRC is absent in chronic renal
failure when protein intake is high.
Renal reserve filtration capacity before and after kidney donation.
P.M. ter Wee, A.M. Tegzess. S. Meijer, A.J.M. Donker. Division of
Neph,'obogv, State University Hospital, Groningen, The Netherlands.
After uninephrectomy glomerular filtration rate (GFR) and effective
renal plasma flow (ERPF) amount to 65% of the values before nephrec-
tomy. Thus, renal reserve filtration capacity may be diminished after
kidney donation. Therefore, we investigated the effect of dopamine
(1.5-2.0 .rg/kg/min for 2 hours) and amino acids (Vamin N; 83 mI/hour
for 16 hours) on GFR (clearance of 251-iothalamate) and ERPF (clear-
ance of 311-hippurate) of 14 kidney donors before (BN) and < 3 months
after (AN) nephrectomy. After kidney donation, serum creatinine
increased from 86 mol/liter (SEM 2.6) to 128 tsmol/liter (sEM 4.6;
P < 0.01). Heart rate and mean arterial pressure did not differ before
and after nephrectomy. Compared to BN, GFR amounted to 60.9%
(SEM 2.1) AN and ERPF 65.2% (SEM 3.2). Dopamine infusion
increased GFR and ERPF significantly BN and AN. Percentage dopa-
mine-induced (Do%) rises in GFR and ERPF were significantly less
AN compared to BN. Amino acid infusion also increased GFR signif-
icantly in BN and AN. However, the percentage amino acid-induced
(AA%) rise in GFR BN did not differ compared to AN. Thus, it is
concluded that the mechanism which is stimulated with dopamine
infusion (that is, predominant efferent vasodilation) is involved in the
renal adaptation to a loss of nephrons, whereas the mechanism which is
stimulated with amino acids (that is, predominant afferent vasodilation)
is not.
BN mean
BL
GFR
100
zDo%
120b
ZAA%
9.0
BL
ERPF
431
zDo%
329k
AA%
8.1"
SEM 5.3 1.7 1.9 23.8 3.8 3.5
AN mean 67 6.1 8.8 281 22.9 5.8
SEM 3.0 1.1 2.8 9.1 l.7 2.4
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"P < 0.05, h P < 0.01, meat vs. placebo
a NS versus baseline (BL); h p < 0.05 BN versus AN
1034 Abs/nuts
Unimpaired sodium excretion after acute salt loading in hypoprotein-
emic dogs. J.A. Joles, I-l.A. Kootnans, E.J. Dot/iou! Mees, Depart inent
of Nephrology, (In iversity Hospital, Utrecht, The Netherlands. In
conscious dogs fluid retained during plasmapheresis can be excreted at
a plasma colloid osmotic pressure (COP) of 9 to 10 mm Hg (control 22
mm Hg). To further define the effect of hypoproteinemia on kidney
function, we studied the effect of an iv. infusion of one liter Ringer's
lactate on Na excretion (UN3V, jzmol/min) and renal hemodynamics in
6 conscious dogs in which plasma protein concentration (PPC) was
reduced from 68 to 36 g/liter (COP 21 to 9 mm Hg) by plasmapheresis
and a low protein diet. GFR and ERPF (mi/mm/kg) were measured by
continuous infusion of inulin and PAH, respectively. Delivery from the
proximal tubule was assessed by the fractional excretion (FE,%) of
lithium.
Normoproteinemia
after
Hypoproteinemia
after
before Ringer's before Ringer's
—-
PPC 68 3 57 3CC 36 2 31 i
cIFR 3.5 0,3 4.3 0.2" 2.9 0.l 3.5 o.r-5
ERPF 11.3 1.4 11.3 1.0" 06 11.4 0.9"
FF 31.9 1.4 39.0 1.8"'" 31.5 2.1 32.2 3o
UV 4±1 180±57" 28±16 200±61"
FE Na 0.04 0.01 1.7 0.5" 0.4 0.2 2.5 0.8"
FEK 4±1 17±3" 13±2 29T'"
FE Cl 0.03 0.01 1.7 0.7" 0.4 0.2 3.4 0.8"
FELi 2±1 21±3" l23 25±2"
P C o.os "after vs. before Ringer's; hypo- vs. normoproteinemia;
"difference in the change induced by Ringer's
Hypoproteinemia decreased both the GFR and ERPF by the same
degree so that the filtration fraction remained constant. After Ringer's
infusion the GFR rose in both circumstances, but the ERPF rose in the
hypoproteinemic state only. Thus the rise in FF during control condi-
tions was absent in hypoproteinemia. Despite this somewhat different
hemodynamic response, the natriuresis after expansion was not less
during hypoproteinemia. Fractional electrolyte and lithium excretion
rose to levels at least similar to those attained in normoproteinemia. In
conclusion, neither the increase in filtration nor the decrease in reab-
sorption of Na after an isotonic electrolyte load were affected by severe
hypoproteinemia.
Renal handling of s9mTc.DMSA: Peritubular uptake or glomerular
filtration and tubular reabsorption? M.J. c/c Lange, W.H.J. von Luijk,
S. Mej/er, D.A. Piers. University Hospital, Groningen, The Nether-
lands. svmTcdimercaptosuccinic acid (DMSA) is widely used as a static
renal imaging agent. Because of a high binding to serum proteins, it is
generally assumed that the uptake takes place at the peritubular side of
the proximal tubular cell. Clinical observations in patients with proxi-
mal tubular dysfunction (low renal uptake and enhanced urinary excre-
tion of the tracer) and renal artery stenosis (low renal uptake under
captopril treatment), however, suggest uptake by glomerular filtration
and tubular reabsorption. To gain more insight in the renal handling of
DMSA, the following experiments were performed: protein binding
studies; continuous infusion of DMSA together with '31-hippurate and
'251-iothalamate; and analysis of the tracer after excretion in the urine.
In one normal person, renal extraction of DMSA was measured. Protein
binding studies using ultrafiltration and trichloroacetic acid precipita-
tion in human serum both indicated that binding was about 90% (range
88 to 94%). Continuous infusion in 13 persons with normal renal
function gave the following results (mean sri): ERPF 596 98
mt/mm, GFR 131 22 mI/mm, plasma clearance of DMSA 37 7
mI/mm, renal clearance of DMSA (UV/P) 13 4 mI/mm. Since the rate
of filtration of DMSA is determined by the fraction not bound to serum
proteins (10%) and GFR, it can be calculated to be about 13.1 mI/mm.
It thus almost equals the rate of excretion in the urine while the plasma
clearance is about 3 times faster. This indicates that perituhular uptake
plays an important role in the renal handling of DMSA. Thin layer
chromatography in butanol saturated with 0.3 N hydrochloric acid of
human urine voided after a renal scan with DMSA gave one peak of
radioactivity at the same place as the original DMSA solution. When
urine of a rat after a DMSA scan was injected i.v. to a second rat, again
a renal scan was obtained. Renal extraction was shown to be 6%.
Conclusions: DMSA is excreted in the urine in an unaltered form. Part
of the DMSA is filtered, and this amount almost equals the amount that
is excreted in the urine. Although the clinical observations suggest that
the tracer is handled by filtration and reabsorption, the protein binding
studies corroborate the earlier view that peritubular uptake is the major
pathway in the renal handling of DMSA. Both mechanisms thus play a
role.
Lithium clearance (Ci,1) in man and dog: Effects of sodium restriction
and amiloride. W.H. Boer, J.A. Joles, HA. Kootnans, E.J. Dorhoat
Mees. Deportment of Nephrology. University Hospital, Utreeht, The
Netherlands. C11 represents filtrate delivery from the proximal tubules
(PT) if: (a) Li is reabsorbed in the PT in proportion to Na and H1O and
(b) Li is not reabsorbed beyond the PT. However, the steep fall in CLI
observed in rats during Na restriction (FEN. < 0.45%), which could be
abolished by amiloride, suggested that Li can be reabsorbed beyond the
PT in the rat. Whether distal, amiloride-sensitive Li reabsorption also
occurs in Na restricted humans and dogs is unknown. Clearances were
performed over a wide range of Na intakes. In humans, C1,1 decreased
only moderately and gradually at falling Na excretion rates. In contrast,
CLI fell steeply at FEN. values < 0.45% in the dog.
FENa
N=77
>0.45
Man N55
<0.45
N=25
>0.45
Dog N= II
<0.45
FELI% 29.9 5.5 23.6 45" 22.6 2.2 6.9 2.3"
FEN.% 1.20 0.56 0.21 0.11" 1.01 0.84 0.07 0.05"
The effect of amiloride was studied in Na-restricted normal subjects
(N 8, 15 mg p.o.) and dogs (N = 4, 2 mg iv.). a P < 0.01
Man Dog
Control Amiloride Control Amiloride
FEL% 24.1 4.7 23.1 3.6 1.5 1.0 11.6 2.0"
FENC% 0.10 0.04 1.11 0.36" 0.03 0.02 0.41 0.29"
The large, amiloride-sensitive fall in CLI in Na restricted dogs suggests
that FELl underestimates distal filtrate delivery in this situation due to
distal Li reabsorption. The fact that FELl after amiloride barely reached
12% may indicate that: (a) fractional distal delivery can indeed fall to
12% in dogs, (b) luminal amiloride concentration was too low to block
distal Li reabsorption completely, or (c) Li reabsorption occurs in
amiloride-insensitive parts of the canine distal tubule. In contrast, the
gradual fall in FeLl at decreasing Na intakes in man and the absence of
an amiloride effect at FENC values well below 0.45% suggest that this
fall is due to enhanced Li reabsorption in the PT. Thus, FELI may be a
correct index of distal filtrate delivery in Na restricted humans, but not
in Na restricted dogs and rats.
Hemolytic uremie syndrome—A ten year follow-up study of73 patients.
M. c/c' Jong, L. Monnens. Department of Pediatrics, University of
Nijmegen, The Netherlands. A long term follow-up of 73 patients
suffering from the epidemic form of hemolytic uremic syndrome is
presented 10 years after initial acute illness. The patients were subdivided
into three groups, according to the criteria proposed by Gianantonio
and based on the duration of oliguria and/or anuria. Four out of
thirty-eight patients belonging to the first group (mild form) had a
slightly increased blood pressure as the only sequela. Two patients out
of group two (moderate form, N 29) had a slightly diminished GFR,
and a reduced concentrating capacity, some proteinuria and mild
hypertension. Five other patients had slight proteinuria (C 500 mg/24
hr) and one of them a mild hypertension. All 6 patients belonging to the
third group (severe form) had late sequelae: two started hemodialysis
more than ten years after the initial phase; three have a distinctly
decreased GFR and concentrating capacity. The unique remaining
patient with a normal OFR without hypertension had a decreased
concentrating capacity. The importance of careful treatment, especially
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of hypertension, in children with a decreased GFR two years after the
initial phase is stressed.
Genetic linkage between nephrogenic diabetes insipidus and a polymor-
phic DNA marker, DXS 52. N. Knoer,s, H. i'd. Hevden, B.A. v. Oost,
L. Monnens, .1. Wilkins, H.H. Ropers. Departments of fluinan Genet—
and Pediatrics, St.—Radhoud Hospital, Nij,negen, The Netherlands.
Nephrogenic diabetes insipidus (NDI) is a rare X-linked disorder,
characterized by insensitivity of the distal nephron to the antidiuretic
effect of vasopressin. Affected males usually present soon after birth
with polyuria, severe dehydration, fever, vomiting, constipation and
failure to thrive. Without treatment severe dehydration may lead to
death or mental retardation. The biochemical defect underlying the
renal unresponsiveness to vasopressin has not yet been elucidated.
Female carriers of the disease are clinically asymptomatic. Until now,
carrier detection was done by means of a renal concentrating ability
test. However, this test is not fully reliable since norma concentrating
ability does not rule Out the possibility that the female is a carrier of the
disease. Therefore, a better means of carrier identification is of partic-
ular interest. In order to determine the subchromosomal localization of
the NDI locus on the X-chromosome, we have employed a set of
evenly-spread restriction fragment-length polymorphisms, defined by
DNA probes. Eleven families with NDI from the Netherlands were
examined. No recombination was observed with the DXS 52 marker,
which maps at Xq28 and is defined by the probe Stl4. The maximum
combined lod (log of odds) score was 8.97. This finding indicates tight
linkage between NDI and DXS 52 (90% confidence limits 0 to 6%) and
assigns the NDI locus to the subtelomeric region of the X-chromosome
long arm. The establishment of a closely-linked diagnostic marker is not
only useful for reliable carrier identification, but also provides a first
step towards isolating the gene itself.
Factors determining therapeutic response and long-term outcome in
patients with extracapillary glomerulonephritis. G.M.M. Vervoort,
J.F.M. Wetzels, J.L.J. Jansen, P.G.G. Gerlag, S.J. Hoorntje, K.J.M.
Assmann, J.H.M. Berden. Division of Nephrology, University Hospital
Njjinegen; Grootziekenga,sthuis, Den Bosch, St. Jo,seph Hospital,
Eindhoven; and Catharina Hospital, Eindhoven; The Netherlands.
Prognostic factors and response to immunosuppressive therapy were
studied retrospectively in 56 patients with extracapillary glomerulone-
phritis (ECGN). Only patients with a biopsy-proven ECGN were
included, while patients with SLE or Schonlein-Henoch purpura were
excluded. There were 29 male and 27 female patients with a mean (±
SD) age of 56 15 years. These patients could be divided into three
groups: idiopathic ECON (group I; N = 22), ECGN secondary to
vasculitis (group II; N = 25), and anti-GBM glomerulonephritis (group
111: N = 9). All but three patients were treated with corticosteroids and
cytotoxic drugs, 18 patients were additionally treated with extensive
plasma exchange. Overall I year renal survival was 45% and 1 year
patient survival 73%. Recovery of renal function in treated patients with
anti-GBM glomerulonephritis was extremely low, only one out of nine
patients showing improvement. Between group I and 11 no differences
were observed in renal survival. A worse prognosis in group t and 11
was significantly related to the presence of oliguria at presentation, to a
high initial serum creatinine, to a high percentage (> 80) of glomeruli
with crescents, and to the presence of immunoglobulin deposits on
immunofluorescence. All patients who responded to therapy did so
within 6 weeks after the start of treatment. Treatment with extensive
plasma exchange did not improve the results. Mortality in patients not
responding to therapy was significantly higher (48% than that in
patients responding to therapy (16%). This mortality was mainly due to
infections and cardiovascular complications. In conclusion, im-
munosuppressive treatment of non-anti-GBM ECGN leads to recovery
of renal function in 66% of the patients. It is, however, doubtful
whether immunosuppressive treatment is indicated in patients with
anti-GBM nephritis.
Cyclosporine A(CsA) in patients with idiopathic nephrotic syndrome.
R. Zietse, G.J. Wenting, P. Kramer, M.A.D.H. Schalekamp and W.
Weimar. Departments of Internal Medicine I, University Hospital
Rotterdam, St. Clara Hospital, Rotterdam, The Netherlands. We
studied the effects of CsA in 12 patients with idiopathic nephrotic
syndrome refractory to treatment with prednisone and/or other im-
munosuppressants, in a dose of 6 mg/kg, for three months. Plasma
through levels (RIA) were kept between 50 and ISO ng/ml. Diagnoses
included: idiopathic mernbranous ON (IMGN, 6), focal segmental OS
(3) mesangioproliferative GN (I), minimal change disease (I) and
proliferative GN (I). We also included 3 patients with Alport's syn-
drome (AS) in which changes in proteinuria would most likely be due to
changes in renal hemodynamics. Proteinuria decreased in II of the IS
patients from 10.1 4.6 to 4.1 2.6 g/24 hr (mean SD; P < 0.01;
ANOVA). In five of the responding patients, including all 3 patients
with AS, creatinine clearance (Ccr) decreased from 76 25 to 46 13
mI/mm (P < 0.01). In 6 responders including 5 of the 6 patients with
IMON. no decrease in Ccr was observed. CsA may decrease protein-
uria by renal hemodynamic changes as in patients with AS, where
immunosuppression is unlikely to cause structural changes to the GBM.
In IMON where no decrease in Ccr was observed the effects of CsA
may be due to its immunosuppresive action.
Recurrent activity of Wegener's granulomatosis during long-term
dialysis and transplantation. M. Jadoul, Ri. Hené. Department of
Nephrology University Hospital Utrecht, The Netherlands. Wegener' s
granulomatosis (WG) has previously been considered to usually be-
come and remain inactive after initiation of dialysis, despite low or no
immunosuppressive treatment. However, this assumption was based on
a small number of patients treated with dialysis for short periods. We
have dialyzed 5 patients with WG for longer periods (6 to 72 months),
3 of whom experienced recurrence of active severe WO during dialysis
(hemodialysis in 2, CAPD in 1). Two patients initially presenting with a
rapidly progressive glomerulonephritis first manifested extrarenal
symptoms during dialysis. We traced 31 more evaluable dialyzed
patients with WO in the literature. In 13 of them WG, either previously
recognized or misdiagnosed as idiopathic rapidly progressive glomeru-
lonephritis, 000dpasture's or Henoch Schönlein syndrome, reactivated
after initiation of dialysis. Specific treatment required for respiratory
tract manifestations was delayed due to lack of awareness that WO may
reactivate during chronic dialysis. In 6 patients (2 in our unit), activa-
tion of WG contributed significantly to death. We traced twenty
patients with WG in the literature who have been transplanted. In 4,
WO reactivated during treatment with azathioprine and prednisone,
leading to graft loss once. No data are known to us about transplanted
patients with WG immunosuppressed with cyclosporine. The present
data have obvious implications. In contrast to systemic lupus
erythematosis, WG frequently reactivates and causes major complica-
tions during dialysis. Thus, drug therapy should not be discontinued too
early in patients starting with dialysis while WG is active. Moreover,
when manifestations compatible with active WG occur during dialysis
or after transplantation, reactivation of WG should be seriously sus-
pected, even in patients with a previous presumptive diagnosis of
idiopathic rapidly progressive glomerulonephritis, 000dpasture or
Henoch Schonlein syndrome.
Correction of phagocytic deficiency in hemodialyzed patients by a new
cephalosporin. S. Ringoir, N. Van Landschoot, R. Vanholder. Renal
Division, University Hospital, Ghent, Belgium. Chronic renal failure is
characterized by increased susceptibility for infections. In vitro exper-
iments suggest that CefodizimeR (C), a new cephalosporin, causes an
increase in phagocytic capacity. Therefore, the in vivo effect of a
treatment with C on phagocytosis was studied in 10 hemodialyzed
patients by measuring the '4C02 production during the metabolization
of radioactive glucose by phagocytic cells, in the resting state and after
activation by Latex or Zymosan. Two grams of C were injected iv.
after each dialysis during 2 weeks, phagocytosis was studied before and
after these two weeks. In the Table, the production of '4C0, (Dpm x
l0) is represented in normal subjects and in the hemodialyzed patients
(HD) under study:
Resting state
After Latex
Normals
N=27
12.6 4.6
40.9 19.5
HD before C
N=10
5.6 1.4'
17.9 l1.9
HD after CN=l0
6.3
27.4 7,8b
Ater Zymosan 94.1 34.6 48.4 24.9 78.8 151b
"P < 0.01 vs. normal; b P < 0.01 vs. before C
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Treatment with C improved the response of the depressed phagocytosis
after the challenge by Latex or Zymosan. A similar treatment with
co-trimoxazole had no effect on phagocytic function. in conclusion,
these results reveal a stimulation in vivo of the depressed phagocytic
system of the uremic dialysis patient by the new cephalosporine
CefodizimeR.
Differences in the peritoneal transport of water, solutes and proteins
between dialysis with 2 and 3 liter exchanges. R.T. Krediet, E.W.
Boeschoten, D.G. Strujjk, L. Arisz. Renal Unit, Academic Medical
Centre, Amsterdam, The Netherlands. In 8 CAPD patients who had
insufficient dialysis (6) or loss of ultrafiltration (2) on a normal CAPD
scheme, the time course of the intraperitoneal volume (IPV), the
lymphatic absorption rate (LAR), and transport kinetics of low molec-
ular weight solutes (LMWS): urea (U), lactate (L), creatinine (C),
glucose (G), middle molecules (MM): kanamycin (K). inulin (I), and
proteins (P): 32-microglobulin, albumin, IgG, were studied, Dialysate
containing G 13.6 g/liter, K 50 mg/liter, 1 2.5 g/liter and autologous
hemoglobin (AH) as marker for IPV and LAR was used to compare a 2
liter, 4 hr exchange with a 3 liter, 4 hr one. Both studies were done
within 1 week. Dialysate samples were taken every 30 mm. LAR was
calculated as the difference between AU instilled and AH recovered,
divided by AHnean. IPV increased initially, followed by a linear
decrease. Marked interindividual variations were present. IPVmcan was
2534 81 ml (x sEM) and 3356 85 ml. During the last 2 hrs IPVijter
was lower than IPV2iiter (P < 0.05). Water reabsorption rate (WRR)
was 0.94 0.25 mI/mm (2 liter) and 2.18 0.30 (3 liter, P < 0.01). This
was caused by a higher LAR during 3 liter: 3.39 0.31 (3 liter) vs. 1.87
0.34 mI/mm (2 liter, P < 0.01). Peritoneal mass transfer (MT) was
higher during 3 liter than 2 liter for LMWS and K (P < 0.01), but
unchanged for I and P. Mass transfer area coefficients (MTAC) re-
mained unaltered, except for C (11.9 mI/mm vs. 15.8, P < 0.01). Both
during 2 liter and 3 liter MTAC of all solutes proved a power function
of molecular weight (MW). For LMSW and MM the slopes were 0.37
0.03 (2 liter) and 0.33 0.02 (3 liter) and for p 1.22 0.07 and 1.20
0.08. It is concluded that CAPD with a 3 liter exchange leads to a high
WRR from the peritoneal cavity caused by increased lymphatic absorp-
tion. Also MT of LMWS is higher during 3 liter. Probably due to
increased convective transport, MTAC are increased for MM. For both
volumes the relationship between MTAC and MW was similar.
Long term effects of CAPD on carbohydrate and lipid metabolism. N.
Lameire, D. Matthys, R. Beheydt, Renal Division, University Hospital,
Gent, Belgium. In 9 non-diabetic CAPD patients, followed for 6 years,
peritoneal glucose absorption and response of blood glucose and plasma
insulin to a hypertonic glucose dialysate were prospectively studied.
Glucose absorption per day remained constant and ranged between 135
g and 145 g over the years. Blood glucose and plasma insulin levels
during a 4.25% glucose dwell increased from normal values to peak
levels of 1.8 g/l and 4 times the basal insulin levels, respectively.
Neither the blood glucose nor the insulin response changed over 6
years. The plasma triglyceride levels increased from 215 32 to 310
64 mg/dI over 6 years. A linear correlation between peritoneal glucose
absorption and rise in triglycerides was found after 1 year of CAPD but
could not be established after 6 years. Cross sectional determinations of
HDL, HDL2 and HDL3 cholesterol in non-diabetic CAPD patients
demonstrated persistently low normal values for all HDL fractions.
However, apoprotein A1 levels rose from subnormal to normal values
after 6 years (from 101 19 mg/dlto 149 21 mg/dl). In conclusion, no
major changes in carbohydrate metabolism occur after 6 years of CAPD
in non-diabetic patients. A hypertriglyceridemia rapidly develops and
persists over the years. It is encouraging to note that the "protective"
apoprotein A1 increases to normal values after I year and remain then
constant over 6 years.
High dosage furosemide in hemodialysis patients. R.W. van Olden,
J.J.M. van Meijel, P.G.G. Gerlag, Department of Internal Medicine,
St. Joseph Hospital, Eindhoven, The Netherlands. The effects of 2 g
furosemide during 7 days were studied in 10 patients with end-stage
renal failure treated by hemodialysis, who had some residual renal
function (average 2,6 2.1 mI/mm). Furosemide was administered
orally as 2 tablets of 0.5 g twice daily. In comparison with the control
period all patients showed an increase in diuretic response (median
109%, P <0.005) and an increase in urinary excretion of Na, Cl and
K (median 210%, 366% and 65%, respectively, P < 0.005). The
increase of urea excretion was small (median 29%, P < 0.01) and the
protein excretion did not increase significantly. Between the two
periods there was a reduction of Nat, Cl, K in serum (median 5.0
mmol/liter, 5.5 nimol/liter and 0.6 mmol/liter, respectively, P < 0.005).
Both the mean increase of urinary volume and the excreted amount of
furosemide correlated positively with the residual creatinine clearance
(P < 0.05). Serum furosemide levels in 9 patients never exceeded 40
g/ml but in 1 patient accumulation probably occurred. Patients weight
gain between dialysis treatments decreased (median 1.0 kg. P < 0.01).
In the two patients with the highest ECC (5.6 and 6.4 mI/mm) the initial
dose had to be reduced after the first days to 1.0 or 0.5 g daily, because
of signs of volume depletion. In 5 patients of this study the effects of I
g furosemide during 7 days were studied after a new control period.
There was an increase in urinary volume (median 54%, P = 0.05). This
was about 50% lower than after 2 g furosemide, demonstrating a clear
dose-response relation. No important electrolyte shifts appeared in 15
hemodialysis patients treated with 0.5 to 2 g furosemide daily during a
period of 3 months. The only side effects were temporary vague
abdominal complaints. No ototoxicity could be demonstrated by re-
peated audiometry. The results of treatment with high dosage furose-
mide suggested better control of water and salt balance and improve-
ment of the quality of life in hemodialysis patients.
Tubular site of action of diuretics: A comparison of lithium clearance
and free-water clearance techniques. J.F.M. Wetzels. F.H.J.A. v.
Heusden, F.Th.M. Huysmans, A.J. Hoit,sma, R.A.P. Koene. Depart-
ment of Medicine, Division (f Nephrology, University Hospital
Nijmegen, Nijinegen, The Netherlands. To elucidate the role of lithium
as a marker of proximal tubular sodium transport, we have studied the
natriuretic effects of several, differently acting diuretics in healthy
young volunteers. Acetazolamide (Ac; N = 8), furosemide (F; N = 8),
ethacrynic acid (E; N 9), hydrochlorothiazide (H; N = 8), amiloride
(Am; N 6), or placebo were randomly administered orally during
maximal water diuresis. We used both the fractional free water clear-
ance (fCH2O) technique and fractional lithium clearance (FELi) to
estimate fractional proximal tubular sodium reabsorption (FPRNA).
FPRNA(1) was calculated as 100— (UNA+K . V/ECCXPNA/x 100) —
fCH2O, FPRNA (2) as 1-FELi. Mean (± sEM) maximal changes of
fractional excretion of sodium (FENA), fCH2O, and FPRNA (I), and
FPRNA (2), as compared to placebo are given in the table.
Ac F
FENA% 2.1 03b 6.2 14b
FPRNA(l)% —5.6 0.5" —6.5 1.5"
FPRNA(2)% 94 —8.3 ÷ 16h
MCH2O% 2.8 04b —0.1 10b
P < 0.05, b p < 0.01, 0.05 <P < 0.10, compared to placebo
E H Am
4.8 11b 2.1 02" 1.0 0jb
—3.1 l.la
—1.5 0.4" —1.9 04b
1b —0.8 05b
—2.6 l.2c
—2.0 05b —0.8 0.3' 1.0 0.3
Both methods to calculate FPRNA correlated well (r = 0.87; P < 0.001).
Furthermore the change in FELi corrected for the increase of FENA
correlated significantly with the change in fCH2O (r = 0.71; P <0.001).
Conclusion: the use of lithium clearance in this study was equivalent to
the conventional method in determining proximal tubular sodium trans-
port. The decrease in FPRNA, as measured by FELi and fCH2O, after
administration of E and Am suggests an additional effect of these drugs
on the proximal tubule. Alternatively, it could be possible that both
methods are not valid as measures of proximal sodium reabsorption.
Is urinary angiotensin excretion a marker of renal production? P.
Boer, W.H. Boer, H.A. Koomans, E.J. Dorhout Mccv. Department of
Nephrology and Hypertension, University Hospital, Utrecht, The
Netherland,c. Literature on urinary angiotensin land II excretion (UAI,
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VA!!) is scarce. If excretion reflects local intrarenal production, it is
conceivable that in some situations discrepancies arise between
changes in urinary excretion and plasma concentration (PA!. PAIl). We
studied these variables in 7 healthy volunteers in 3 different situations:
1) on a low Na diet before and during infusion (5 mg/mm) of
chlorothiazide (CT); Na losses were replaced by infusion of saline; 2)
On a free Na diet before and after injection of 10 mg furosemide (F); 3)
in the upright and supine posture on free and low Na intakes. Diuresis
was ensured by oral water loading and substitution of urinary loss by
drinking of water. Timed urine portions were collected and correspond-
ing midpoint blood samples were obtained. Samples were collected with
appropriate inhibitors to prevent metabolization or conversion of angi-
otensins. Al and All were purified and concentrated by reversed phase
column chromatography and measured by radioimmunoassay. Results:
1) During CT infusion, PAl and PAIl decreased from 43 to 35 and 20 to
15 pmol/liter (P < 0.05), whereas UAI and VAIL tended to remain
constant (75 to 88, and 59 to 59 pmol/min). Inulin clearance decreased
from 106 to 93 mI/mm. 2) After F, VAt and VAIl were increased (78 to
151, and 67 to 121 pmol/min; P <0.05). The increases of PA! and PAll
were smaller (29 to 34, and II to 15 pmol/liter). In most subjects
maximum values for VAIL were reached immediately after injection of
F, while maximal PAIl values were reached later. 3) PAl and PA!!
increased (P < 0.05) after stimulation by upright posture or low Na
intake (free Na: 26 to 35, and 9 to IS, low Na: 48 to 80, and 24 to 38
pmol/liter), whereas VAt and VALE did not change significantly (free
Na: 71 to 61, and 60 to 63, low Na: 78 to 80, and 85 to 98 pmol/min). The
different patterns of urinary and plasma angiotensins suggest that they
reflect different phenomena. Possibly, most urinary angiotensin repre-
sents renal production.
Plasma potassium and aldosterone and the kaliuresis after an acute
potassium load in man. R.J. Hené, HA. Koo,nans, P. Boer, A.J.
Rahelink, E.J. Dorhout Mees. Department of Nephrologv, University
Hospital, Utrecht, The Netherlands. Adjustments of renal potassium
(K) excretion to increased K intake involves several factors, among
which is a (moderate) elevation of plasma K and aldosterone. In
humans, little is known with respect to the relative importance of these
factors. We studied the relation between plasma K and renal K
excretion after an acute K load (1 mmol KCI/kg body wt) in 6 healthy
males in normal conditions and during states of hyper- and hypo-
minera!ocorticism simulated by, respectively, the use of fludrocortisone
(F, 0.5 mg bid) and spironolactone (S, 50 mg qid). The latter studies
were done after escape from the Na-retaining and natriuretic effect of
these drugs. Na/K intake was fixed on 100/100 mmol daily. Every
subject underwent a control (no K load) and K-load clearance study of
6 hours duration in each condition. A steep relation between plasma K
(ordinate) and urine K (abscissa) was found, compatible with a strong
influence of changes in plasma K on K excretion. F shifted the relation
to a lower level of plasma K, S shifted it to a slightly higher plasma K,
in accordance with potentiation by aldosterone of the influence that
plasma K exerts on kaliuresis. Paradoxically, the K load was excreted
less efficiently during F, probably due to enhanced cellular K deposi-
tion. The K load had no effect on glomerular filtration rate (inulin
clearance), but was always acutely natriuretic. Relative to the transient
rise in plasma K and in natriuresis the kaliuresis was prolonged, but not
when the K load was taken during the use of F or S. Prolonged
kaliuresis likely reflects a delayed effect of aldosterone. of which the
plasma concentration rose and fell parallel to plasma K only in the study
without F or S. These studies delineate the separate roles of changes in
plasma K and aldosterone in the renal excretion of a K load in humans.
Development of progressive gLomerular sclerosis (PGS) in experimental
chronic serum sickness (CSS). PCW Hogendoorn, JA Bru,jn, EWA
Ge/ok, LJCM v.d. Broek, and GJ Fleuren, Department of Pathology,
University of Leiden, The Netherlands. A rat model of CSS was used to
study the pathogenesis of PGS complicating experimental immune
complex glomerulonephritis. CSS was induced by immunizing Wistar
rats with bovine serum albumin (BSA) followed by i.p. administration
of the antigen. Early lesions consisted of mesangial deposits of rat IgG
and tgM, later followed by transient subenclothelial and persistent
subepithelial 1g. On the basis of the peak level of proteinuria around day
80, three groups of rats were distinguished: I. < 50 mg/24 hr, not
differing significantly from controls; 11. 50 to 500 mg/24 hr; and III. >
500 mg/24 hr. The animals were killed 220 days after immunization and
the presence of mesangial proliferation (A). epithelial proliferation and
synechiae (B), focal glomerulosclerosis and hyalinosis (C) as well as
normal glomeruli (D) was scored in 100 glomeruli per animal:
A B C D
Group I
II
III
Controls
17%
48%
28%
16%
7%
8%
13%
4%
1%
15%
50%
1%
75%
29%
9%
79%
it appeared that all and only proteinuric animals (groups 11 and Ill)
developed PGS, although all animals passed through a phase of mesan-
gial and subendothelial deposition of rat 1g. A strong correlation was
found between the degree of proteinuria and the proportion of glomeruli
affected, which was highest in animals of group Ill. These observations
permit the conclusion that the combination of mesangial and subendo-
thelial Ig on the one hand and subepithelial Ig associated with increased
protein loss on the other constitute a conditio sine qua non for the
development of PGS in this model. Finally, the composition of the PGS
lesions was investigated. Using specific antibodies, the presence of
laminin and type LV collagen, but not of types I and LII collagen in areas
of PGS was shown. This indicates that the development of PGS in this
model is due to an increased production of basement membrane
components by glomerular cells after the occurrence of immunological
glomerular injury.
Membranoproliferative glomerulonephritis with inflammation of thejuxtaglomerular distal tubule. AM. Jonker, J.D. Elema. Department of
Pathology, University of Groningen, The Netherlands. A case of a
six-year-old girl with a membranoproliferative glomerulonephritis
(MPGN) is reported. Laboratory tests revealed decreased C3, moderate
increased AST, positive ANF and a negative c d DNA. Histology
showed MPGN and an acute inflammatory process of neutrophilic and
eosinophilic granulocytes and a few lymphocytes in the macula densa
and adjoining distal tubule referred to as the juxtaglomerular distal
tubule (JDT). In 110 counted JDT's 31 showed no abnormalities, but in
79 the described inflammation was seen. Proximal and distal tubules at
other sites showed no abnormalities. Mesangial depositions of C3 and
specific, but weak depositions of 1gM around the JDT were detected by
immunofluorescent microscopy. Other tubular areas were negative.
Electronmicroscopy showed subendothelial and sporadic subepithelial
electron dense depositions in the glomerulus, but no depositions were
found in the JDT area. Data reported from experiments involving rats
and mice led to speculations that macromolecular material, removed by
the mesangium, may be eliminated via a pathway draining into the area
of juxtaglomerular apparatus (JGA) and JDT. On the basis of these
experiments it is speculated that the JDT inflammation accompanying
the MPGN resulted from deposition of immune-reactive material drain-
ing from the glomerular mesangium.
Concomittant hydergine (H) administration does not result in a favor-
able modification of cyclosporine A induced renal dysfunction (Cyrd). J.J.
Hoinan van der Heide, S. Me(jer, Wi. van Son, A.M. Tegzess.
University Hospital, Groningen, The Netherlands. Acute Cyrd is
associated with a renal vasoconstriction. Recently some contradictory
reports concerning attempts to modify Cyrd with concomittant admin-
istration of vasodilating agents have been published. We studied the
effect of concomittant H administration on acute Cyrd. In a randomized
prospective study of 31 consecutive renal transplant patients all receiv-
ing cyclosporine A (CyA), 17 received concomittant H (Hf) while the
other 14 served as controls (H). All patients received a cadaveric graft
in 1986. H was administered postoperatively for 4 weeks in a dose of 9
mg a day orally. H and H— groups were comparable regarding donor
age, acceptor age, total ischemia time, CyA whole blood level and the
percentage of patients receiving rejection treatment. After 4 weeks
renal function was measured by serum creatinine (Scr; [tmol), creati-
nine clearance (Ccr; mI/mm) and glomerular filtration rate as measured
by clearance of iothalamate (GFR; mI/mm). Median values of renal
function in the H group were Scr: 203, Ccr: 35 and GFR: 28, while
those of the H group were 175,46 and 4!, respectively. To rule out the
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detrimental effect of rejection treatment patients with (R) and without
rejection treatment (R) were analyzed separately. The R population
receiving H had a Curof52 and a OFR of 41 while the controls had 63
and 49, respectively. In the R4 group the results were similar, with the
H group having a C, of 30 and a GFR of 24 while the controls had 37
and 37, respectively. We conclude that no beneficial effect of H
administration on acute Cyrd could be demonstrated in this study.
The influence of cyclosporine or dietary protein restriction on chronic
renal allograft rejection. A.M.M. Kootte and L.C. Paul. Departtoent of
Nephrology, University Hospital, Leiden, The Netherlands. Chronic
renal allograft rejection is characterized by progressive decline in graft
function that is apparently not influenced by intensification of conven-
tional immunosuppression. We studied the effectiveness of conversion
of azathioprine to cyclosporine (CsA; S mg/kg/day) or maintaining the
immunosuppressive regimen but reducing the dietary protein intake to
0.33 g/kg/day. Both groups and a control group were randomly selected
and consisted of 7 patients each. The serum creatinine values (Sc1 in
smol/liter; mean sEas) at the time of the intervention were 285 48
(Csa group), 306 43 (protein restricted group), or 222 10 (controls).
After 18 months follow-up, the 5cr were 434 40 (N = 6), 235 19 (N
= 5) and 346 14 (N = 6), respectively; four patients had returned to
dialysis. to the patients who were converted to CsA, the Sç, values
remained generally stable after an initial increase of the S, during the
first 3 months of CsA. In the protein-restricted patients the 5Cr
decreased, especially when the protein restriction was started when the
5Cr was < 130 prnol/liter. to the controls, the 5c1 deteriorated at a
constant rate. Since both CsA and dietary protein restriction decline the
rate of deterioration of graft function, renal hemodynamic factors that
are influenced by CsA or protein intake may be important in the
progression of chronic graft rejection.
Angiotensin converting enzyme inhibition (ACEi) improves the sensi-
tivity of renography and urography in detecting renal artery stenosis: an
animal study. G.J. Jonker, D. de Zeeuw, R.M. Haisman, U.K. van der
Hem. Department qf Nephrology, State University Hospital,
Graningen, The Netherlands. Non-invasive diagnostic techniques for
renovaseular hypertension (RVH) such as rapid sequence urography(RSU) and hippurate renography (RE) fail to detect 20 to 25% of
potentially curable patients. One of the reasons for this may be that the
renin-angiotensin system prevents function loss of the post-stenotic
kidney so that differences between the stenotie and non-stenotie kidney
are not detected by these tests. We studied the sensitivity of RE and
RSU before and during ACEi in conscious, salt-depleted 2-kidney,
1-clip Ooldblatt hypertensive dogs instrumented with permanent arte-
rial and venous catheters, electromagnetic blood flow probes around
both renal arteries, and an externally adjustable constrictor around one
renal artery. The dogs were studied before and after induction of a light(N = 5), moderate (N = 4), or severe (N = 2) renal artery stenosis(RAS). Before induction of RAS, RE and RSU showed no left-right
differences in 10 dogs, both without and with ACEi. Interestingly, in
one dog RE (but not RSIJ) was positive before induction of RAS, but
became negative during ACEi. Two to three weeks after induction of
RAS all dogs showed increases in blood pressure. However, only 50%
of RE and 22% of RSU showed differences between the two kidneys,
indicative of the presence of RAS. ACEi had remarkable effects on the
outcome of RE and RSU: all previously negative tests became positive,
and previously existing differences between both kidneys became more
evident. Renal blood flow (RBF) at the stenotie side did not change
during ACEi (146 13 vs. 145 21 mI/mm), whereas eontralateral RBF
showed a clear increase (207 18 vs. 282 20 mI/mm; P < 0.01). The
altered handling of contrast material and radionuclide tracer appeared
not to be related to the change in RBF. In conclusion, ACEi markedly
improves the sensitivity of RSU and RE in the diagnosis of RVH in this
animal model. The effect of ACEi on the specificity of these tests has to
be further investigated, but could possibly be favorable.
Enalapril attenuates natriuresis of atrial natriuretie peptide (ANF) in
man. CA. Gaillard, H.A. Koomans, E.J. Dorhoot Mees. Department
qf Nephrology, University of Utrecht, Utrecht, the Netherlands. We
studied the effect of 4 days enalapril (20 mg t.i.d.) on the response to
ANF in 8 normal subjects balanced on a 100 mmol Na diet. Renal Na
handling was studied in 20 mm clearance periods before and after 100
tg human ANF (99 to t26) bolus injection. Without enalapril, ANF
produced a rise iu iuulin clearance (C), sodium excretion, maximal
free water clearance (C11,0), and "diluting segment solute delivery"
(C0,0 + Cci); fractional lithium reabsorption (FRLi) dropped, and PAH
clearance (CJ'Ajj) did not change. After 4 days of enalapril, mean arterial
pressure had dropped from 86 Ito 79 1 mm Hg; CVAU had risen and
C4 was unchanged. In this condition ANF produced an attenuated rise
in C and excretion of electrolytes whereas CEAII fell. The changes in
markers of renal sodium handling were also attenuated. These results
are in keeping with the notion that the effects of ANF on renal hemo-
dynamics and sodium handling may depend on renal angiotensin II.
No drug Enalapril
Baseline ANFBaseline ANF
C1ml/min
CPA0 mI/mm
U0V ,wnol/min
[CH2O+Cci]/Cjn
CH2O/C1 %
FRLi %
109±7"
569 48
127 19"
12.7 1.3"
11.9 1.2"
66.2 2.1"
121
554
437
15.7
13.0
61.2
8
48
103
2.1
1.5
3.1
III
696
117
11.3
10.4
71.9
4
35"
22"
1.1
0.9
1.5
115
646
242
12.3
10.7
70.1
41
63
1.5
1.1
2.0
"P < 0.05
A comparison between the peritoneal transport of serum proteins and
neutral dextrans in CAPD patients. R. T. Krediet, G.C.M. Koomen,
MG. Koop,oan, F.J. Hock, D.G. Stroijk, E.W. Boeschoten, L. Arisz.
Renal Unit. Academic Medical Centre, Amsterdam, The Netherlands.
Fixed negative charge has been found in the peritoneuns of animals. To
analyze whether electrostatic properties of the peritoneum are impor-
tant in the permeability for macromolecules, the peritoneal transport of
negatively-charged serum proteins (SP) and neutral dextrans (ND) of
similar size were compared. The following SP were determined: /32-
microglobulin, albumin, transferrin, IgO and a2-macroglobulin. The
Eiustein-Stokes radii (esr) ranged from 16 to 89 A. Palydisperse ND (esr
22 to 90 A), 130 mg/kg and inulin (I) were given i.v. 3 hours prior to the
experiment. A group of 5 stable CAPD patients was studied during a 4
hour dialysate dwell. Blood samples were taken at 0, 2 and 4 hours.
Following gel permeation chromatography of serum and effluent (con-
centrated by lyophilization), eluted fractions were assayed for ND.
Clearances were expressed as fractional clearance (FC), that is relative
to iuulin. In all patients FC [ND] and FC [SPI decreased the higher the
esr up to 90 A. The shape of the relationship between FC and esr
appeared exponential on a loglogseale. FC ISP] were close to, but
always in excess of FC [ND] of comparable esr. The linear relationship
(LR) was: FC [ND] = 0.63 FC ISP] + 0.32 (r = 0.92, P C 0.001). A LR
can be deduced from Stokes' equation between esr of a solute and the
reciprocal of its free diffusion coefficient in water (D20). The slope of
the LR between esr and a l/D2OW (free diffusion) was 0.07. In each
patient we found a LR between esr and 1/FC, both for SP and ND.
However, the slopes were much steeper than for l/Do: they varied
between 0.46 and 1.61 (mean 0.98) for SP and between 0.98 and 2.27
(mean 1.46) for ND. We conclude that up to 90 A peritoneal transport
of SP and ND is of a similar magnitude and is mainly determined by a
size- and not charge-dependent restricted diffusion.
Demonstration of oxygen free radical involvement in adriamycin in-
duced decrease of glomerular ATPase activity. K. Poelstra, M.J.
Hardonk, W.W. Bakker. Department of Pathology, University of
Groningen, The Netherlands. Adriamycin (ADR) has been shown to
induce massive proteinuria starting several days after intravenous (iv.)
injection in vivo. As soon as 24 hours following injection of ADR,
decreased glomerular ATPase activity can be demonstrated cytochemi-
eally in the glomerular basement membrane (GBM), using the cerium
based method at the ultrastructural level. Since similar inactivation of
ATPase in the GBM could be induced by local X-irradiation (X-irr.)
upon the kidneys in viva, it was suggested that oxygen free radicals may
be involved in this early damage of the GBM. We now have investigated
the effect of in vivo administration of the well known scavenger
superaxide dismutase (SOD), upon ADR induced decrease of glomer-
ular ATP-activity in adult PVG/e female rats (200 to 250 g). One group
of rats (N = 5) (group I) received ADR (7.5 mg/kg body wt; iv.) and
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subsequently after 5, 60 and 120 mm, 0.2 ml SOD (superoxide dismu-
tase from bovine erythrocytes. Serva Heidelberg/New York; IS mg/kg
b.w. total doses) in saline (first injection iv., the latter injections
intraperitoneally (i.p.)). Group 2 (N = 4) received ADR with subse-
quent iv. and i.p. injections of 0.2 ml saline and group 3 (N = 4)
received the same SOD regime without ADR pretreatment. Group 4 (N
= 4) consisted of rats which received local X-irr. upon the kidney (20
Gy) and animals of group S (N = 4) were treated with identical dose
X-irr. under SOD treatment (5 mg/kg body wt 1 hr before X-irr. and 15
mg/kg body wt divided over 3 injections; 5, 60 and 120 mm after X-irr.).
Kidneys of untreated animals (group 6; N = 3) were used for compar-
ison of ATPase activity. Animals were sacrificed 48 hours after the
treatment with ADR or X-irr. and kidneys were fixed by perfusion and
processed for cytochemistry according to standard methods. The
results show decrease of ATPase activity within the GBM and endo-
thelial cell membranes in rats of group 2 and 4, whereas the activity in
kidneys of group I, group 3 and group 5 rats equals the activity of that
of the untreated rats (group 6). It is concluded that superoxide forma-
tion by ADR may be involved in the early nephrotoxic effect of ADR as
reflected by decreased glomerular ATPase activity.
Effect of mild charge modification of albumin on renal excretion. D. de
Zeeuw, R. Tomasini, M. Haas, P.E. de Jong, J.J. Weening, G.K. van
der Hem. Department of Nephrology and Pathology, Universities of
Groningen and Leiden, The Netherlands. Charge modification of albu-
min and other proteins to cationic range (p1 > 8) increases their
glomerular sieving. Since endogenous human and rat albumin are
present in two differently charged configurations: major part of p1 4.6,
minor part of p1 6.0, we investigated the effect of a mild charge
modification of endogenous rat albumin (RA) on renal excretion in 8
Wistar rats in normal and proteinuric (adriamycin: 2 mg/kg) state.
Normal and chemically modified RA (nRA and inRA) were labelled
with 1-125. p14.6 and 6.5, respectively. With a 7 day interval, fractional
clearance of nRA and mRA (FnRA and FmRA) was measured by a
continuous infusion method (reaching steady-state plasma levels) in
conscious rats with a permanent jugular vein catheter. Urine was
collected by spontaneous voiding over 3 periods each of 1 hour, and
volume, creatinine, and RA-bound radioactivity were measured. The
protocol was repeated in the same rat after proteinuria induction.
During normal state mean FnRA (all data 1000 X) was found to be 0.09
(range 0.05 to 0.l8), whereas mRA was cleared about 12 times faster in
each rat (FmRA: 1.07, range 0.7 to 1.34). The ratio of FnRA and FmRA
was 0.09. After induction of proteinuria FnRA increased 40-fold
(4.21, 1.0 to 7.5), and about equalled FmRA in each individual rat (3.6,
1.1 to 7.1). The FnRA/FmRA ratio in the proteinuric state was 1.4. The
change in FnRA/FmRA ratio from control to proteinuric state seems to
indicate a functional charge defect, but could also be explained by a
small size defect which will contribute more to the clearance of nRA
that is highly restricted under normal conditions. in conclusion, a slight
charge modification of endogenous albumin (within the 'physiological'
anionic range) leads to a drastic increase in its renal clearance. This
finding and the recent observation of Ghiggeri et at (Kidney mt
32:69,1987) showing the presence of less anionic isoforms of albumin in
the urine of patients with minimal change nephropathy, may have
implications for understanding the causes of proteinuria with no obvi-
ous renal pathology.
Reduction of proteinuria by cyclosporine (CsA) in a passive model of
anti-GBM nephritis in the mouse. G. Schrijver, J.F.M. Wetzels, K.J.M.
Ass,nann, J.C.M. Robben, R.A.P. Koene, J.H.M. Berden. Department
of Medicine, Division of Nephrology and Department of Pathology,
University Hospital of Nijmegen, Nmegen, The Netherlands. In
certain auto-immune diseases CsA has beneficial effects. Recently, it
has also been demonstrated, that CsA can reduce proteinuria in various
forms of human and experimental glomerulonephritis. This anti-
proteinuric effect of CsA may be the consequence of diminution of the
immunological damage, drug induced decrease of GFR, or changes in
permselectivity of the glomerular basement membrane (GBM). We
studied the anti-proteinuric effect of CsA in the heterologous phase of
anti-GBM nephritis in the mouse. This model is characterized by acute
glomerular lesions and a dose-dependent albuminuria. Rabbit anti-
mouse GBM antibodies were administered intravenously in CS7BLIO
mice, after three days of pretreatment with either CsA (75 mg/kg body
wt) (N = 15) or olive oil (controls, N = 15) orally. Albuminuria was
measured between 6 and 24 hours after anti-GBM administration. CsA
did not influence the severity of the histological lesions. Albuminuria
was substantially reduced by CsA (CsA; 1.7 1.8, controls; 9.8 3.4
mg/18 hr, P < 0.0001). There was a considerable concomitant reduction
of GFR, as measured with a 51Cr-EDTA single shot method at day —
and 3 (GFR ratio day 3/day —l for CsA; 0.4 0.1, for controls; 0.9
0.6. P < 0.01). However, this drug-induced decrease of GFR was not
solely responsible for the reduction of albuminuria since the fractional
excretion of albumin was significantly lower in the CsA group (0.17
0.16% vs. 0.58 0.26%; P < 0.001). This was further substantiated by
experiments wherein the CsA induced reduction of GFR was prevented
by simultaneous treatment with phenoxybenzamin (PB) twice daily 45
zg orally for four days (GFR ratio day 3/day — I for PB and CsA; 0.9
0.4, controls 0.9 0.6; P = NS). Despite this there was still a significant
reduction of albuminuria (2.2 1.8 vs. 9.8 3.4 mg/18 hr, P <0.001).
In conclusion: the anti-proteinuric effect of CsA in this model seems to
be the result of a reduction of permselectivity of the GBM and not of a
decrease in GFR.
Protective effect of organic anions (OA), PAll, cephalothin, and
atriopeptin III (AP111) on glomerular filtration (GFR) of ischemic rat
kidneys. N. Lameire, E. Matthys, D. Kesteloot, M.A. Waterloos,
University Hospital, Gent, Belgium. The present work studies the effect
of OA on GFR, 90 mm after reflow in unilateral renal ischemia for 40
mm. Two groups were studied, a control group (C) without and an
experimental group (E) with PAH infusion during reflow. In C, GFR
was 0.22 0.06 mI/mm (N = 9) while in E, GFR was 0.64 0.05
mI/mm. Pre-administration of probenecid did not abolish the protective
effect. Challenging the ischemic kidney with cephalothin, another
organic anion instead of PAH resulted in a similar protection (GFR in
clamped kidney with cephalothin, 0.52 0.12 mI/mm vs. control
clamped kidney, 0.22 0.06 mI/mm; P < 0.05). Cimetidine, an organic
base, showed (he same protective effect. in a third series of experi-
ments, the animals were infused with APIII during the first hour of
reflow. After 90 mm, GFR in the clamped kidney was 0.72 0.2 nil/mm
vs. 0.22 0.06 mI/mm in non-APIII infused rats. Monitoring renal
blood flow (RBF) in both control clamped and APIII and PAH treated
animals revealed a similar degree of reflow. It is concluded that in this
experimental model, PAH has a protective action on the GFR in the
ischemic kidney; a similar protection was noted with cephalothin,
another organic acid cimetidine, an organic base and with APIII; the
protection is not due to a better perfusion of the kidneys during reflow.
